ArticleCancer research communications2024

MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer.

Beatriz German et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.